Uterine and Pelvic Conditions Fibroids

Gut Dysbiosis in Selected Gynecological Diseases Associated with Female Infertility: A Scoping Review

Nowakowski Ł, Warchoł K, Kuźniar A, Zimoń B, Skoczylas MM, Marzec P, Krawczyk G, Jegorow D, Pankiewicz R, Warchoł AZ, Banach M, Kuranty K, Olcha P

Published August 29, 2026 Journal of clinical medicine
DOI 10.3390/jcm15176705 PMID 42739710 PMC PMC13565995

RRM Academy Synopsis

Gut microbiome changes may be linked to PCOS and endometriosis

A review of 106 studies examined gut bacteria in women with three conditions linked to infertility. These are polyendocrine metabolic ovarian syndrome (PMOS), formerly polycystic ovary syndrome (PCOS), endometriosis, and uterine fibroids. Gut bacteria changes showed up in all three. The changes were more consistent in PMOS / PCOS and endometriosis than in fibroids.

Key Findings

  • The authors identified 876 records, removed 192 duplicates, screened 684 unique records, and included all 106 full-text articles they assessed.
  • Of the 106 sources, 29 reported standardized microbiome-derived indicators, which were summarized descriptively. No meta-analysis was performed because of heterogeneity in study design, assessment methods, and outcome measures.
  • Findings were more consistent for PMOS / PCOS and endometriosis than for uterine fibroids, where the authors call the evidence limited, with mild and inconsistent reductions in diversity.
  • The authors list common signatures reported across the three conditions: less microbial diversity, a higher Firmicutes/Bacteroidota ratio, more Proteobacteria and Candida fungi, and fewer bacteria that produce short-chain fatty acids.
  • The authors state that no uniform, verified, and validated criteria exist for an unfavorable gut microbiota profile, and that tests based on the microbiome are not yet ready for clinical use.

Interpretation

This scoping review mapped gut microbiome studies across PMOS / PCOS, endometriosis, and uterine fibroids. The review found shared patterns across the three conditions: less microbial diversity, shifts in major bacterial groups, and fewer short-chain fatty acid producers. The authors note that most of the included studies were cross-sectional. The findings support larger, standardized studies of the gut microbiome's role in these conditions.

RRM Context

Restorative reproductive medicine looks for the underlying condition behind infertility. PMOS / PCOS and endometriosis are two of those conditions. This review adds the gut microbiome as a possible inflammatory and metabolic angle on both. The authors write that PMOS / PCOS evidence supports the relevance of diversity measures as assessment tools.

Abstract

Background and Objectives

Female infertility represents a significant public health issue. Available evidence supports the hypothesis that the gut microbiota may play an essential role in women's reproductive health and may serve as a diagnostic or prognostic biomarker in specific gynecological disorders. A substantial part of current research concerns disturbed communication between the hypothalamic-pituitary-ovarian axis and the gut microbiota, providing the basis for analyzing this phenomenon as the gut-ovary axis or the gut-vagina-ovary axis. The primary aim of this scoping review was to map the available evidence on the relationship between gut microbiota composition and female infertility, with particular emphasis on polycystic ovary syndrome (PCOS, currently polyendocrine metabolic ovarian syndrome, PMOS) endometriosis, and uterine fibroids.

Methods

The review was conducted in accordance with the PRISMA Extension for Scoping Reviews (PRISMA-ScR). PubMed, Scopus, and Google Scholar were searched using terms related to gut microbiota, female infertility, PCOS, endometriosis, and uterine leiomyomas. Peer-reviewed publications in English published between 2015 and 2025 were considered. The included studies were descriptively synthesized to identify recurring microbiota patterns and research gaps.

Results

The reviewed evidence indicates that gut dysbiosis may be associated with selected gynecological disorders affecting fertility, including PCOS, endometriosis, and uterine fibroids. The gut microbiome may have potential value as a biomarker supporting diagnosis, treatment selection, and prognosis.

Conclusions

The gut microbiome represents a promising but still insufficiently validated area in the management of gynecological diseases associated with female infertility. Further high-quality clinical studies are needed to verify the effectiveness of microbiome-based therapies and to develop evidence-based guidelines for managing infertility associated with gut dysbiosis.

Read the guides

Topics

By this author

Related research

Uterine and Pelvic Conditions › Fibroids › Fibroids and Fertility · Endometriosis › Fertility and Outcomes › Ovarian Reserve · PMOS / PCOS › Pathophysiology › Hyperandrogenism
Łukasz Nowakowski, Katarzyna Warchoł, Agnieszka Kuźniar, Barbara Zimoń, Michał M Skoczylas, Paweł Marzec, Grzegorz Krawczyk, Dorota Jegorow, Robert Pankiewicz, Andrew Z Warchoł, Maciej Banach, Kinga Kuranty, Piotr Olcha
Ł Nowakowski, K Warchoł, A Kuźniar, Barb Zimoń, B Zimoń, M Skoczylas, P Marzec, G Krawczyk, D Jegorow, Bob Pankiewicz, Rob Pankiewicz, Bobby Pankiewicz, R Pankiewicz, Andy Warchoł, Drew Warchoł, A Warchoł, M Banach, K Kuranty, P Olcha
PMID 42739710 42739710 DOI 10.3390/jcm15176705 10.3390/jcm15176705 Nowakowski et al. 2026, Nowakowski 2026